Table 3 Five- and 10-year melanoma-specific survival rates according to TNM version 7 and TNM version 8 stage
From: Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
TNM version 8 | TNM version 7 | |||||||
|---|---|---|---|---|---|---|---|---|
Stage | 5 year | 95% CI | 10 year | 95% CI | 5 year | 95% CI | 10 year | 95% CI |
I | 98.20 | 97.20–99.10 | 95.20 | 93.50–96.9 | 98.20 | 97.20–99.10 | 95.20 | 93.50–96.9 |
IA | 98.46 | 97.24–99.69 | 96.37 | 94.34–98.44 | 100 | 100–100 | 93.13 | 83.33–100 |
IB | 97.98 | 96.51–99.47 | 94.46 | 91.79–97.2 | 97.57 | 96.16–99 | 94.77 | 92.5–97.09 |
II | 90.50 | 88.50–92.70 | 84.70 | 82.00–87.50 | 90.50 | 88.50–92.70 | 84.70 | 82.00–87.50 |
IIA | 92.86 | 89.96–95.85 | 89.07 | 85.41–92.89 | 92.86 | 89.96–95.85 | 89.07 | 85.41–92.89 |
IIB | 91.47 | 88.04–95.03 | 83.31 | 78.46–88.46 | 91.47 | 88.04–95.03 | 83.31 | 78.46–88.46 |
IIC | 83.63 | 77.58–90.16 | 75.11 | 67.53–83.54 | 83.63 | 77.58–90.16 | 75.11 | 67.53–83.54 |
III | 59.20 | 55.90–62.70 | 51.00 | 47.50–54.90 | 59.20 | 55.90–62.70 | 51.00 | 47.50–54.90 |
IIIA | 87.86 | 79.21–97.46 | 85.61 | 76.28–96.09 | 76.13 | 70.89–81.76 | 68.53 | 62.51–75.11 |
IIIB | 72.7 | 65.86–80.25 | 64.75 | 57.16–73.34 | 53.76 | 47.62–60.68 | 45.93 | 39.64–53.22 |
IIIC | 51.77 | 47.31–56.65 | 40.48 | 35.77–45.82 | 44.59 | 38.93–51.07 | 34.07 | 28.27–41.06 |
IIID | 40.72 | 31.09–53.34 | 36.49 | 26.7–49.86 | NA | NA | ||